C14H22N4O4
310.35 g/mol
Pharmaceutical IntermediateWarning
N,N'-Bis(tert-butoxycarbonyl)-1H-pyrazole-1-carboxamidine
CAS152120-54-2EC629-085-8
Category
Pharmaceutical Intermediate
Compound Class
Heterocycle
Primary Use
Pharmaceutical Intermediate
This compound is a protected guanidine-building block used as an intermediate in pharmaceutical manufacturing. It features a pyrazole ring and two tert-butoxycarbonyl (Boc) protecting groups, making it suitable for controlled synthesis of guanidine-containing molecules.
Pharmaceutical intermediate for guanidine synthesis
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing N,N'-Bis(tert-butoxycarbonyl)-1H-pyrazole-1-carboxamidine?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Related Compounds
ReferenceSame Category
(S)-4-(4-Aminobenzyl)-2(1H)-oxazolidinone
CAS152305-23-2
pharmaceutical intermediate
ReferenceSame Category
(3R,4R)-4-fluoropyrrolidin-3-ol hydrochloride
CAS1523530-25-7
pharmaceutical intermediate
ReferenceSame Category
(3S,4R)-rel-3-(Boc-amino)-4-fluoropiperidine
CAS1523530-35-9
pharmaceutical intermediate
ReferenceSame Category
Rac-(1r,3s)-3-amino-1-methylcyclobutan-1-ol hydrochloride
CAS1523606-23-6
pharmaceutical intermediate
Safety Reference
Warning
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
Identifiers
IUPAC Name
tert-butyl N-[[(2-methylpropan-2-yl)oxycarbonylamino]-pyrazol-1-ylmethylidene]carbamate
InChIKey
QFNFDHNZVTWZED-UHFFFAOYSA-N
SMILES
CC(C)(C)OC(=O)NC(=NC(=O)OC(C)(C)C)N1C=CC=N1
Synonyms (23)
- Bis-Boc-pyrazolocarboxamidine
- Laninamivir Impurity 4
- N,N'-Bis-Boc-1-Guanylpyrazol
- N,N-Bis-Boc-1-Guanylpyrazole
Sourcing N,N'-Bis(tert-butoxycarbonyl)-1H-pyrazole-1-carboxamidine?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.